CD8A and Cirrhosis: Importantly, changes in CD4 + and CD8 + T cells are not only reflected in numbers and subpopulations, but co-stimulatory molecules and immune checkpoints on these cells are upregulated and the production of pro-inflammatory cytokines is significantly reduced [217], and these changes may increase the risk of infection and ACLF in patients with cirrhosis.